|
|
|
|
Daiichi aims to double profits by 2013
Free newsletter via e-mail Related Stories Tools Daiichi Sankyo is aiming high: The Japanese drugmaker announced that it aims to almost double profits in three years.To do that, it intends to boost revenue by 20 percent, counting on a.) overseas expansion, b...
|
|
|
LIFE SCIENCES: Japanese pharma is aiming high
(Reuters) - Daiichi Sankyo, Japan's third-largest drugmaker, said on Friday it aims to nearly double its annual operating profit and increase revenue by a fifth in three years as it expands sales, especially overseas.Daiichi Sankyo bought a majority stake in...
|
|
|
Daiichi aims to double profits by 2013
Daiichi Sankyo is aiming high: The Japanese drugmaker announced that it aims to almost double profits in three years.To do that, it intends to boost revenue by 20 percent, counting on a.) overseas expansion, b.) the resurgence of its generics subsidiary...
|
|
|
FDA Gives Red Light to Ranbaxy for Generic Flomax
_ FDA Gives Red Light to Ranbaxy for Generic Flomax.
|
|
|
FDA Gives Red Light to Ranbaxy for Generic Flomax
_ FDA Gives Red Light to Ranbaxy for Generic Flomax.
|
|
|
FDA approves generic version of Flomax
_ FDA approves generic version of Flomax.
|
|
|
Impax Laboratories Gets Final FDA Approval for Generic Flomax 0.4...
Company: Impax Laboratories, Inc.(IPXL) Impax Laboratories, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application (ANDA) for the generic version of Flomax ...
|
|
|
Impax Laboratories Gets Final FDA Approval for Generic Flomax 0.4mg Capsules
Impax Laboratories, Inc.has announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application (ANDA) for the generic version of Flomax (tamsulosin hydrochloride) 0.4mg capsules.
|
|
|
Impax Laboratories Receives Final FDA Approval for Generic FLOMAX 0.4mg Capsules and Immediately Commences S
Impax Laboratories, Inc.(NASDAQ: IPXL) today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Companys Abbreviated New Drug Application (ANDA) for the generic version of FLOMAX (tamsulosin hydrochloride) 0...
|
|
|
Impax Laboratories Receives Final FDA Approval for Generic FLOMAX 0.4mg Capsules and Immediately Commences Shi
HAYWARD, Calif.-- (BUSINESS WIRE) -- Impax Laboratories, Inc.(NASDAQ: IPXL) today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Companys Abbreviated New Drug Application (ANDA) for the generic version of ...
|
|
|
Impax Laboratories Receives Final FDA Approval for Generic FLOMAX 0.4mg Capsules and Immediately Commences Shi
- Impax Laboratories, Inc.(NASDAQ: IPXL) today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application (ANDA) for the generic version of FLOMAX (tamsulosin hydrochloride)...
|
|
|
Impax Laboratories wins FDA approval for BPH drug
(Datamonitor via COMTEX) Impax Laboratories, a specialty pharmaceutical company, has reported that the FDA has granted final approval of the company's abbreviated new drug application for the generic version of Flomax 0.4mg capsules.The company has...
|
|
|
Impax Laboratories Receives Final FDA Approval For Generic FLOMAX(R) 0.4mg Capsules And Immediately Commences Shipment
Impax Laboratories, Inc.(NASDAQ: IPXL) announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application (ANDA) for the generic version of FLOMAX (tamsulosin hydrochloride) 0.4mg...
|
|
|
FDA Gives Red Light to Ranbaxy for Generic Flomax
Up until a week ago, Ranbaxy was banking that its generic version of Astellas enlarged prostate treatment Flomax was going to clear FDA and help boost the flailing company.But things appear to have gone awry for the Indian firm. FDA Gives Red Light...
|
|
|
3/3/10 - FDA approves Flomax for treatment of benign prostatic hyperplasia
- The US Food and Drug Administration announced yesterday that it has approved the first generic version of Flomax Capsules 0.4 mg (tamsulosin hydrochloride) to treat benign prostatic hyperplasia (BPH).Gary Buehler, director of the FDA's Office of...
|
|
|
FDA Approves First Prostate Generic
The US Food and Drug Administration (FDA) has approved the first generic version of Flomax, used to treat benign prostatic hyperplasia (BPH), a condition where an enlarged prostate gland causes problems with urination.The generic tamsulosin capsules,...
|
|
|
Impax Laboratories wins FDA approval for BPH drug
Impax Laboratories, a specialty pharmaceutical company, has reported that the FDA has granted final approval of the company's abbreviated new drug application for the generic version of Flomax 0.4mg capsules.Impax Laboratories wins FDA approval for BPH...
|
|
|
Impax Laboratories wins FDA approval for BPH drug
Impax Laboratories, a specialty pharmaceutical company, has reported that the FDA has granted final approval of the company's abbreviated new drug application for the generic version of Flomax 0.4mg capsules.Impax Laboratories wins FDA approval for BPH...
|
|
|
FDA Approves Impax Laboratories Generic Flomax 0.4mg Capsules
FDA has granted final approval of the Impax Laboratories (Impax) abbreviated new drug application (ANDA) for the generic version of Flomax (tamsulosin hydrochloride) 0.4mg capsules.Impax has also initiated shipment of the drug through its generic...
|
|
|
Impax Laboratories' generic FLOMAX ANDA: FDA grants final approval
Impax Laboratories, Inc.(NASDAQ: IPXL) today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Companys Abbreviated New Drug Application (ANDA) for the generic version of FLOMAX (tamsulosin hydrochloride) 0...
|
|
|
Ranbaxy flubs launch of generic Flomax
Ranbaxy Laboratories has run up against regulatory troubles yet again.The company was supposed to be set for a March 2 launch of generic Flomax, the Astellas Pharma urology drug. As first to file for FDA approval, Ranbaxy has that coveted exclusivity...
|
|
|
3/2/10 - FDA Approves First Generic Tamsulosin to Treat Enlarged Prostate Gland
Condition known as benign prostatic hyperplasia common in older men SILVER SPRING, Md., March 2 /PRNewswire-USNewswire/ The U.S.Food and Drug Administration today approved the first generic version of Flomax Capsules 0.4 mg (tamsulosin hydrochloride)...
|
|
|
FDA approves Flomax for treatment of benign prostatic hyperplasia
- The US Food and Drug Administration announced yesterday that it has approved the first generic version of Flomax Capsules 0.4 mg (tamsulosin hydrochloride) to treat benign prostatic hyperplasia (BPH).Gary Buehler, director of the FDA's Office of...
|
|
|
FDA approves Flomax for treatment of benign prostatic hyperplasia
- The US Food and Drug Administration announced yesterday that it has approved the first generic version of Flomax Capsules 0.4 mg (tamsulosin hydrochloride) to treat benign prostatic hyperplasia (BPH).Gary Buehler, director of the FDA's Office of...
|
|
|
Generic version of Flomax Capsules receives FDA approval
Condition known as benign prostatic hyperplasia common in older men The U.S.Food and Drug Administration today approved the first generic version of Flomax Capsules 0.4 mg (tamsulosin hydrochloride) to treat benign prostatic hyperplasia (BPH), a...
|
